1/4
About Polydex

As far back as 1969, we have been engaged in the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry as well as the manufacture and marketing of biotechnology-based products for human pharmaceutical markets. Business is conducted through our wholly-owned subsidiaries, Dextran Products in Canada and Chemdex in the United States.

 

Common Shares

 

Shares Issued & Outstanding  -  3,399,978

An OTC Pink Foreign Issuer - POLXF

​Electronically Quoted with OTC Markets

Fiscal Year End  -  January 31st

Currently a SEC non-reporting issuer 

Recent News

 

September 16, 2019

Polydex Pharmaceuticals Ltd.

Reports 2nd Quarter Financial Results

Positive Cash Flow Key to Forward Momentum

Polydex Pharmaceuticals

Investor Relations

Find us

 Limited

Contact:



Linda C. Hughes
Polydex Investor Relations
 

E-Mail PolydexIR@gmail.com

Copyright 2013 All Rights Reserved  Polydex Pharmaceuticals Limited.